Staging prognostic discussions about glioblastoma.

Area of Science:

• Oncology
• Neuro-oncology
• Medical Ethics

Background:

• Effective communication of prognostic information is crucial for glioblastoma patients.
• Current practices in prognostic disclosure by neuro-oncologists are often ineffective and not routine.

Purpose of the Study:

• To propose a novel framework for staged disclosure of prognostic information in glioblastoma.
• To balance ethical obligations with effective patient communication and advance care planning.

Main Methods:

• A narrative review of empirical data on prognostic disclosure in cancer and glioblastoma.
• Development of a normative framework integrating clinical, ethical, and empirical insights.

Main Results:

• A staged disclosure framework is proposed, discussing incurability and neurocognitive decline early.
• Life expectancy estimations are deferred to a later visit, allowing for complete pathology results and trust-building.

Conclusions:

• Staged prognostic discussions optimize communication for glioblastoma patients and families.
• This approach balances oncologists' ethical duties and improves patient autonomy and advance care planning.
• Further empirical research is needed to validate this staged disclosure method.